This super-extremophile, using genetic instructions from a few different microbes, would create a complex a molecule called Acetyl Coenzyme-A, or Acetyl Co-A for short.
In the case of a newer drug class called biologics, the cost could be even higher, as they are highly complex large-molecule medicines that cannot be easily produced.